Renal Toxicity of Interleukin-2 Administration in Patients With Metastatic Renal Cell Cancer: Effect of Pre-therapy Nephrectomy-Reference-Cited by-同舟云学术

Renal Toxicity of Interleukin-2 Administration in Patients With Metastatic Renal Cell Cancer: Effect of Pre-therapy Nephrectomy

Published:1989-03 Issue:3 Part 1 Volume:141 Page:499-502
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Belldegrun Arie¹,Webb David E.¹,Austin Howard A.¹,Steinberg Seth M.¹,Linehan W. Marston¹,Rosenberg Steven A.¹

Affiliation:

1. From the Surgery Branch, and Biostatistics and Data Management Section, Division of Cancer Treatment, National Cancer Institute, and Kidney Diseases Section, National Institutes of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference7 articles.

1. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone;Rosenberg;New Engl. J. Med.,1987

2. Clinical effects and toxicity of interleukin-2 in patients with cancer;Lotze;Cancer,1986

3. Effects of interleukin-2 on renal function in patients receiving immunotherapy for advanced cancer;Belldegrun;Ann. Intern. Med.,1987

4. Adoptive immunotherapy of cancer using lymphokine activated killer cells and recombinant interleukin-2;Rosenberg,1986

5. Chi-square tests with one degree of freedom: extensions of the Mantel-Haenszel procedure;Mantel;J. Amer. Stat. Ass.,1963

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The High-Dose Aldesleukin “Select” Trial: A Trial to Prospectively Validate Predictive Models of Response to Treatment in Patients with Metastatic Renal Cell Carcinoma;Clinical Cancer Research;2014-11-25

2. High-dose Interleukin-2 Therapy for Metastatic Renal Cell Carcinoma: A Contemporary Experience;Urology;2014-05

3. Nierenzellkarzinom;Uroonkologie;2014

4. Immunotherapy and Targeted Therapy Combinations in Renal Cancer;Current Clinical Pharmacology;2011-08-01

5. Immunotherapy for Renal Cell Carcinoma;Hematology/Oncology Clinics of North America;2011-08